Foundation for Multisystemic Smooth Muscle Disease

A2A PARTNERS

Genetic Alliance UK


Genetic Alliance UK is the leading organization supporting people with genetic, rare, and undiagnosed conditions in the UK. It advocates for faster, more accurate diagnoses and access to high-quality care for those with genetic conditions like ACTA2 mutations-related diseases.



The Alliance works closely with policymakers and the public to promote advancements in rare disease research, including conditions such as MSMDS. Through collaboration with member organizations, it aims to improve healthcare policies and support research efforts that benefit the genetic disease community.

Gene People- Partnership Networks


The Gene People Partnership Network fosters collaboration among charities and patient groups supporting those affected by genetic conditions, including diseases related to ACTA2 mutations. The network allows the sharing of resources and knowledge to improve the quality of life for individuals with rare genetic disorders like MSMDS.


Through its collaborative efforts, the Partnership Network raises awareness of genetic diseases, supports research initiatives, and promotes stronger connections between patient communities and healthcare professionals.


Share4Rare


Share4Rare is a global platform where patients, caregivers, clinicians, and researchers come together to make a difference in rare diseases, including genetic conditions like ACTA2 mutation disorders. The platform empowers individuals through shared knowledge and experience, collective intelligence, and social innovation.



By facilitating the donation of clinical data and connecting rare disease communities, Share4Rare supports research into conditions like MSMDS, helping to overcome the challenges associated with the limited number of patients and lack of research opportunities.

Global Genes-Global Advocacy Alliance


Global Genes is dedicated to improving the lives of the 400 million people worldwide affected by rare diseases, including those caused by ACTA2 mutations. . As one of the largest patient communities in the world, they stand together to cultivate equity, diversity, and inclusion in rare disease research, ensuring that all perspectives are represented.


Through global collaborations and educational initiatives, Global Genes promotes research into genetic conditions such as MSMDS, working to improve diagnosis, care, and treatment for rare disease patients across diverse communities.


Share by: